KOBIOLABS

mbiomics

This company develops live bacterial therapeutics and a microbiome profiling platform to treat patients with cancer and inflammatory bowel diseases.

Microbiotica

This company develops live bacterial therapeutics and biomarkers for patients with inflammatory bowel disease and advanced melanoma.

MRM Health

This biopharmaceutical company develops microbiome-based live biotherapeutic products for patients with chronic inflammatory diseases and immune-oncology conditions.

Vedanta Biosciences

This company develops microbiome-based oral therapies using bacterial consortia to treat patients with gastrointestinal and immune-mediated diseases.

Bloom Science

This biotechnology company develops microbiome-based oral therapeutics for patients with rare neurological conditions and metabolic disorders like obesity and epilepsy.

EnteroBiotix

This biopharmaceutical company develops orally administered microbial therapeutics for patients with gastrointestinal diseases, including irritable bowel syndrome and blood cancers.

Scioto Biosciences

This company develops live bacterial therapeutics and delivery platforms to treat patients with autism, gastrointestinal disorders and neonatal intestinal conditions.

Enterbiotix

This company develops orally administered microbiome therapeutics to treat patients with gastrointestinal conditions including irritable bowel syndrome and liver cirrhosis.